Literature DB >> 19071000

How age affects the biology of breast cancer.

G A Thomas1, R C F Leonard.   

Abstract

Breast cancer incidence increases with age, but there are important age-related differences with respect to the frequency of different tumour subtypes with respect to hormone receptor status and pathological grade. In general, younger patients show a higher frequency of oestrogen receptor-negative, higher-grade tumours, whereas in older patients there is a higher frequency of oestrogen receptor-positive, low-grade tumours. This accounts for the fact that, in general, elderly patients are thought to have a less aggressive form of the disease. However, this does not mean that all elderly patients with breast cancer necessarily have a good prognosis. An increased understanding of the mechanisms of tissue ageing and how these affect the molecular biological phenotype of breast cancers in cohorts of different ages will aid the oncologist's confidence in tailoring treatment more appropriately to the likely prognosis, and the development of novel, hopefully less toxic, treatments for specific subtypes of breast cancer in the elderly population.

Entities:  

Mesh:

Year:  2008        PMID: 19071000     DOI: 10.1016/j.clon.2008.11.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  20 in total

1.  Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.

Authors:  Giuseppe Sergi; Giulia Pintore; Cristina Falci; Nicola Veronese; Linda Berton; Egle Perissinotto; Umberto Basso; Antonella Brunello; Silvio Monfardini; Enzo Manzato; Alessandra Coin
Journal:  J Bone Miner Metab       Date:  2011-12-13       Impact factor: 2.626

2.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

3.  Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

Authors:  Esther M de Kruijf; Esther Bastiaannet; Francesca Rubertá; Anton J M de Craen; Peter J K Kuppen; Vincent T H B M Smit; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  Mol Oncol       Date:  2014-04-08       Impact factor: 6.603

4.  Contextual Analysis of Breast Cancer Stage at Diagnosis Among Women in the United States, 2004.

Authors:  Steven S Coughlin; Lisa C Richardson; Jean Orelien; Trevor Thompson; Thomas B Richards; Susan A Sabatino; Wei Wu; Darryl Cooney
Journal:  Open Health Serv Policy J       Date:  2009-01-01

5.  Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.

Authors:  L M Boerman; A J Berendsen; P van der Meer; J H Maduro; M Y Berger; G H de Bock
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

6.  Pre-tumor exercise decreases breast cancer in old mice in a distance-dependent manner.

Authors:  Jorming Goh; Emma Endicott; Warren C Ladiges
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

7.  Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Susan E McCann; Lilian U Thompson; Jing Nie; Joan Dorn; Maurizio Trevisan; Peter G Shields; Christine B Ambrosone; Stephen B Edge; Hsin-Fang Li; Christina Kasprzak; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2009-12-22       Impact factor: 4.872

8.  A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables.

Authors:  David Endesfelder; Nicholas McGranahan; Nicolai J Birkbak; Zoltan Szallasi; Maik Kschischo; Trevor A Graham; Charles Swanton
Journal:  Oncotarget       Date:  2011-07

9.  Gene expression in "young adult type" breast cancer: a retrospective analysis.

Authors:  Rebecca H Johnson; Pingzhao Hu; Cheng Fan; Carey K Anders
Journal:  Oncotarget       Date:  2015-05-30

10.  Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer.

Authors:  Chris P Verschoor; Jennie Johnstone; Jamie Millar; Michael G Dorrington; Mojtaba Habibagahi; Alina Lelic; Mark Loeb; Jonathan L Bramson; Dawn M E Bowdish
Journal:  J Leukoc Biol       Date:  2013-01-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.